Clinical features of immature leukemias in children
International Journal of Hematology · 2024
DOI: 10.1007/s12185-024-03771-7 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Hematology, 2024. Verfasst von Daichi Sajiki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Induction Chemotherapy. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Japanese Red Cross Aichi Medical Center Nagoya First Hospital Research Grant.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL), mixed phenotypic acute leukemia (MPAL), and acute myeloid leukemia with minimal differentiation (AML-M0) all originate from immature hematopoietic progenitor cells and have a poor prognosis. We investigated the clinical characteristics of these immature leukemias in 17 children (ETP-ALL: 8, MPAL: 5, AML-M0: 4) at seven institutions. Clinical and laboratory findings were comparable across disease types. Eleven and six patients received ALL- and AML-oriented induction chemotherapy, with six and four achieving complete remission (CR), respectively. Five additional patients achieved CR after salvage with the other type of chemotherapy. Eight patients received hematopoietic cell transplantation (HCT) in first CR, and six survived without relapse. However, six of seven patients who did not receive HCT during first CR relapsed; all underwent HCT later, and only three survived. The 5-year event-free survival (EFS) and overall survival (OS) rate were 37% and 69%, respectively. Patients who achieved CR after induction chemotherapy and received HCT in first CR had favorable EFS and OS. Notably, all patients who received HCT in first CR survived 5 years after diagnosis. Appropriate induction chemotherapy and HCT in first CR could improve the outcome of immature leukemias.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, 3-35 Michishita-Cho, Nakamura-Ku, Nagoya, 453-8511, Japan.
- Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Department of Pediatrics, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
- Department of Pediatric Hematology, Gifu Municipal Hospital, Gifu, Japan.
- Department of Pediatrics, Anjo Kosei Hospital, Anjo, Japan.
Förderung
- Japanese Red Cross Aichi Medical Center Nagoya First Hospital Research Grant
Zitieren
APA
Sajiki, D., Yoshida, N., Muramatsu, H., Sakaguchi, K., Maeda, N., Yokoyama, N., Miyajima, Y., Tanaka, M., Takahashi, Y., & Hama, A. (2024). Clinical features of immature leukemias in children. International Journal of Hematology. https://doi.org/10.1007/s12185-024-03771-7
Vancouver
Sajiki D, Yoshida N, Muramatsu H, Sakaguchi K, Maeda N, Yokoyama N, et al. Clinical features of immature leukemias in children. International Journal of Hematology. 2024. doi:10.1007/s12185-024-03771-7
BibTeX
@article{Sajiki2024,
author = {Sajiki, Daichi and Yoshida, Nao and Muramatsu, Hideki and Sakaguchi, Kimiyoshi and Maeda, Naoko and Yokoyama, Norifumi and Miyajima, Yuji and Tanaka, Makito and Takahashi, Yoshiyuki and Hama, Asahito},
title = {Clinical features of immature leukemias in children},
journal = {International Journal of Hematology},
year = {2024},
doi = {10.1007/s12185-024-03771-7}
}
EUVIMED